August 6, 2025

Multiple Myeloma: A Modern Look at an Ancient Disease and 2025’s Therapeutic Breakthroughs – Pharmacy Times

July 28, 2025

There is No Cure for Multiple Myeloma – but a Clinical Trial Brought One Patient Hope | URMC Newsroom – University of Rochester Medical Center

July 23, 2025

Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders | Leukemia – Nature

July 22, 2025

Multiple Myeloma Highlights From the 2025 ASCO and EHA Annual Meetings

Several presentations at the 2025 American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) Annual Meetings introduced new and updated study data in multiple myeloma (MM), along with potentially significant advancements in therapy. Data presented at the meetings included the following: Quads as gold standard for high-risk newly diagnosed MM (NDMM) Novel treatment […]

July 21, 2025

The State of Blenrep: What Patients Should Know

Updated 7/25/2025 Blenrep (belantamab mafodotin) has now been approved for use in both the European Union and Canada—clear signals that international health authorities recognize its clinical value and potential to improve access to care for patients with relapsed/refractory multiple myeloma. In the U.S., the FDA has extended its review process with a new target date […]